Bionano Genomics, Inc. (BNGO) Free cash flow 2017–2025
Bionano Genomics, Inc. (BNGO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$16.3MFY2025 · since FY2017: -$21.8M → -$16.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$16.3M | +76.3% |
| FY2024 | -$69.0M | +45.6% |
| FY2023 | -$126.9M | +0.3% |
| FY2022 | -$127.2M | — |
| FY2020 | -$38.3M | -29.5% |
| FY2019 | -$29.6M | -45.9% |
| FY2018 | -$20.3M | +7.1% |
| FY2017 | -$21.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BNGO financial trends
BNGO RevenueBNGO Net incomeBNGO Net marginBNGO Gross profitBNGO Gross marginBNGO Operating incomeBNGO Operating marginBNGO Operating cash flowBNGO Capital expendituresBNGO Return on equityBNGO Stock buybacksBNGO Dividends paidBNGO Total assetsBNGO Total liabilitiesBNGO Shareholders’ equityBNGO overview →